These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8844835)

  • 1. Structure and humanization of a rat monoclonal Fab to human interleukin-5.
    Cook WJ; Walter LJ; Murgolo NJ; Chou CC; Petro M; Zavodny PJ; Narula SK; Ramanathan L; Trotta PP; Nagabhushan TL
    Protein Eng; 1996 Jul; 9(7):623-8. PubMed ID: 8844835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-dimensional structures of the free and antigen-bound Fab from monoclonal antilysozyme antibody HyHEL-63(,).
    Li Y; Li H; Smith-Gill SJ; Mariuzza RA
    Biochemistry; 2000 May; 39(21):6296-309. PubMed ID: 10828942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humanization of the mouse anti-Fas antibody HFE7A and crystal structure of the humanized HFE7A Fab fragment.
    Haruyama H; Ito S; Miyadai K; Takahashi T; Kawaida R; Takayama T; Hanzawa H; Hata T; Yamaguchi J; Yoshida-Kato H; Ichikawa K; Ohsumi J; Yonehara S; Serizawa N
    Biol Pharm Bull; 2002 Dec; 25(12):1537-45. PubMed ID: 12499636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human-engineered monoclonal antibodies retain full specific binding activity by preserving non-CDR complementarity-modulating residues.
    Studnicka GM; Soares S; Better M; Williams RE; Nadell R; Horwitz AH
    Protein Eng; 1994 Jun; 7(6):805-14. PubMed ID: 7937712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody humanization by redesign of complementarity-determining region residues proximate to the acceptor framework.
    Hanf KJ; Arndt JW; Chen LL; Jarpe M; Boriack-Sjodin PA; Li Y; van Vlijmen HW; Pepinsky RB; Simon KJ; Lugovskoy A
    Methods; 2014 Jan; 65(1):68-76. PubMed ID: 23816785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen.
    Chen Y; Wiesmann C; Fuh G; Li B; Christinger HW; McKay P; de Vos AM; Lowman HB
    J Mol Biol; 1999 Nov; 293(4):865-81. PubMed ID: 10543973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure and specificity of the anti-digoxin antibody 40-50.
    Jeffrey PD; Schildbach JF; Chang CY; Kussie PH; Margolies MN; Sheriff S
    J Mol Biol; 1995 Apr; 248(2):344-60. PubMed ID: 7739045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure of Fab198, an efficient protector of the acetylcholine receptor against myasthenogenic antibodies.
    Poulas K; Eliopoulos E; Vatzaki E; Navaza J; Kontou M; Oikonomakos N; Acharya KR; Tzartos SJ
    Eur J Biochem; 2001 Jul; 268(13):3685-93. PubMed ID: 11432734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three-dimensional structures of the free and the antigen-complexed Fab from monoclonal anti-lysozyme antibody D44.1.
    Braden BC; Souchon H; Eiselé JL; Bentley GA; Bhat TN; Navaza J; Poljak RJ
    J Mol Biol; 1994 Nov; 243(4):767-81. PubMed ID: 7966295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How the anti-(metal chelate) antibody CHA255 is specific for the metal ion of its antigen: X-ray structures for two Fab'/hapten complexes with different metals in the chelate.
    Love RA; Villafranca JE; Aust RM; Nakamura KK; Jue RA; Major JG; Radhakrishnan R; Butler WF
    Biochemistry; 1993 Oct; 32(41):10950-9. PubMed ID: 8218161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structures of a rat anti-CD52 (CAMPATH-1) therapeutic antibody Fab fragment and its humanized counterpart.
    Cheetham GM; Hale G; Waldmann H; Bloomer AC
    J Mol Biol; 1998 Nov; 284(1):85-99. PubMed ID: 9811544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of Fab hGR-2 F6, a competitive antagonist of the glucagon receptor.
    Wright LM; Brzozowski AM; Hubbard RE; Pike AC; Roberts SM; Skovgaard RN; Svendsen I; Vissing H; Bywater RP
    Acta Crystallogr D Biol Crystallogr; 2000 May; 56(Pt 5):573-80. PubMed ID: 10771426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of NMC-4 fab anti-von Willebrand factor A1 domain.
    Celikel R; Madhusudan ; Varughese KI; Shima M; Yoshioka A; Ware J; Ruggeri ZM
    Blood Cells Mol Dis; 1997; 23(1):123-34. PubMed ID: 9215757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. X-ray structures of fragments from binding and nonbinding versions of a humanized anti-CD18 antibody: structural indications of the key role of VH residues 59 to 65.
    Eigenbrot C; Gonzalez T; Mayeda J; Carter P; Werther W; Hotaling T; Fox J; Kessler J
    Proteins; 1994 Jan; 18(1):49-62. PubMed ID: 7908437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VEGF and the Fab fragment of a humanized neutralizing antibody: crystal structure of the complex at 2.4 A resolution and mutational analysis of the interface.
    Muller YA; Chen Y; Christinger HW; Li B; Cunningham BC; Lowman HB; de Vos AM
    Structure; 1998 Sep; 6(9):1153-67. PubMed ID: 9753694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-dimensional structure of an Fab-peptide complex: structural basis of HIV-1 protease inhibition by a monoclonal antibody.
    Lescar J; Stouracova R; Riottot MM; Chitarra V; Brynda J; Fabry M; Horejsi M; Sedlacek J; Bentley GA
    J Mol Biol; 1997 Apr; 267(5):1207-22. PubMed ID: 9150407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between the antigen and antibody is controlled by the constant domains: normal mode dynamics of the HEL-HyHEL-10 complex.
    Adachi M; Kurihara Y; Nojima H; Takeda-Shitaka M; Kamiya K; Umeyama H
    Protein Sci; 2003 Oct; 12(10):2125-31. PubMed ID: 14500870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure of a cocaine-binding antibody.
    Larsen NA; Zhou B; Heine A; Wirsching P; Janda KD; Wilson IA
    J Mol Biol; 2001 Aug; 311(1):9-15. PubMed ID: 11469854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural evidence for a constrained conformation of short CDR-L3 in antibodies.
    Teplyakov A; Obmolova G; Malia TJ; Luo J; Gilliland GL
    Proteins; 2014 Aug; 82(8):1679-83. PubMed ID: 24470236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Spatial structure of a Fab-fragment of a monoclonal antibody to human interleukin-2 in two crystalline forms at a resolution of 2.2 and 2.9 angstroms].
    Fokin AV; Afonin PV; Mikhaĭlova IIu; Tsygannik IN; Mareeva TIu; Nesmeianov VA; Pangborn W; Lee N; Duax W; Siszak E; Pletnev VZ
    Bioorg Khim; 2000 Aug; 26(8):571-8. PubMed ID: 11040993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.